What is the role of alpha-lipoic acid in the treatment of diabetic neuropathy?

Updated: Jan 17, 2020
  • Author: Dianna Quan, MD; Chief Editor: Romesh Khardori, MD, PhD, FACP  more...
  • Print

In a multicenter placebo-controlled trial of the antioxidant alpha-lipoic acid, Ziegler and colleagues reported short-term symptomatic relief of neuropathy symptoms in patients with type 2 diabetes and symptomatic neuropathy. [18] Other studies of this drug are ongoing.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!